Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16231978.
- Also identified by PMC identifier 1261512.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Greaves discusses a new study in <i>PLoS Medicine</i> that takes us closer to being able to adopt a pharmacogenetic approach to reduce bleeding risk from coumarin therapy.
Medical subject headings
- Anticoagulants
- Coumarins
- Pharmacogenetics